Effects of 12 mg vs. 6 mg dexamethasone on thromboembolism and bleeding in patients with critical COVID-19 - a post hoc analysis of the randomized, blinded COVID STEROID 2 trial

BACKGROUND: Thromboembolism is more common in patients with critical COVID-19 than in other critically ill patients, and inflammation has been proposed as a possible mechanism. The aim of this study was to investigate if 12 mg vs. 6 mg dexamethasone daily reduced the composite outcome of death or th...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonmarker, Sandra, Alarcón, Felix, Litorell, Jacob, Granholm, Anders, Alm, Eva Joelsson, Chew, Michelle, Russell, Lene, Weihe, Sarah, Madsen, Emilie Kabel, Meier, Nick, Leistner, Jens Wolfgang, Mårtensson, Johan, Hollenberg, Jacob, Perner, Anders, Kjær, Maj-Brit Nørregaard, Munch, Marie Warrer, Dahlberg, Martin, Cronhjort, Maria, Wahlin, Rebecka Rubenson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979892/
https://www.ncbi.nlm.nih.gov/pubmed/36862239
http://dx.doi.org/10.1186/s13613-023-01115-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979892/
https://www.ncbi.nlm.nih.gov/pubmed/36862239
http://dx.doi.org/10.1186/s13613-023-01115-y

Ejemplares similares